ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Gallo Publishes Study to Resolve controversy Over HIV Discovery

March 15, 1991

ASCO Places Ad To Urge Increase In Research Funding.

June 13, 2008

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

Carbone Heads Chairmen’s Group

June 30, 1978